{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:58:26Z","timestamp":1778043506272,"version":"3.51.4"},"reference-count":25,"publisher":"American Association for Cancer Research (AACR)","issue":"14","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In previous studies, we showed the possibility of expanding in vitro polyclonal CTL lines directed against patient leukemia cells using effector cells derived from both HLA-matched and HLA-mismatched hematopoietic stem cell donors. Some CTL lines, especially those derived from an HLA-disparate donor, displayed residual alloreactivity against patient nonmalignant cells. In this study, we evaluated the possibility of separating in vitro CTLs with selective graft-versus-leukemia (GVL) activity from those potentially involved in the development of graft-versus-host disease (GVHD) through single T-cell cloning of antileukemia polyclonal CTL lines. We showed that CTLs that were expanded from a single T-cell clone (TCC), able to selectively kill leukemia blasts and devoid of alloreactivity towards nonmalignant cells, can be obtained from antileukemia alloreactive polyclonal CTL lines. TCCs expressed a wide repertoire of different T-cell receptor (TCR)-V\u03b2 families, mainly produced IFN\u03b3 and interleukin 2, irrespective of CD8 or CD4 phenotype, and could be extensively expanded in vitro without losing their peculiar functional features. The feasibility of our approach for in vitro separation of GVL from GVH reaction opens perspectives for using TCCs, which are selectively reactive towards leukemia blasts, for antileukemia adoptive immune therapy approaches after hematopoietic stem cell transplantation, in particular from HLA-mismatched donors. (Cancer Res 2006; 66(14): 7310-6)<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-0591","type":"journal-article","created":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T18:20:34Z","timestamp":1153246834000},"page":"7310-7316","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Single-Cell Cloning of Human, Donor-Derived Antileukemia T-Cell Lines for <i>In vitro<\/i> Separation of Graft-versus-Leukemia Effect from Graft-versus-Host Reaction"],"prefix":"10.1158","volume":"66","author":[{"given":"Daniela","family":"Montagna","sequence":"first","affiliation":[{"name":"1Department of Pediatrics, Laboratory of Immunology, University of Pavia; and"},{"name":"2Pediatric Hematology-Oncology Unit and Laboratory of Immunology, Pediatric Hematology-Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liane","family":"Daudt","sequence":"additional","affiliation":[{"name":"2Pediatric Hematology-Oncology Unit and Laboratory of Immunology, Pediatric Hematology-Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[{"name":"2Pediatric Hematology-Oncology Unit and Laboratory of Immunology, Pediatric Hematology-Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrica","family":"Montini","sequence":"additional","affiliation":[{"name":"2Pediatric Hematology-Oncology Unit and Laboratory of Immunology, Pediatric Hematology-Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Turin","sequence":"additional","affiliation":[{"name":"2Pediatric Hematology-Oncology Unit and Laboratory of Immunology, Pediatric Hematology-Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Lisini","sequence":"additional","affiliation":[{"name":"2Pediatric Hematology-Oncology Unit and Laboratory of Immunology, Pediatric Hematology-Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Giorgiani","sequence":"additional","affiliation":[{"name":"2Pediatric Hematology-Oncology Unit and Laboratory of Immunology, Pediatric Hematology-Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ester","family":"Bernardo","sequence":"additional","affiliation":[{"name":"2Pediatric Hematology-Oncology Unit and Laboratory of Immunology, Pediatric Hematology-Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Maccario","sequence":"additional","affiliation":[{"name":"2Pediatric Hematology-Oncology Unit and Laboratory of Immunology, Pediatric Hematology-Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2006,7,18]]},"reference":[{"key":"2022061622264972600_B1","doi-asserted-by":"crossref","unstructured":"Appelbaum FR. The current status of hematopoietic cell transplantation. Annu Rev Med\u20082003; 54: 491\u2013512.","DOI":"10.1146\/annurev.med.54.101601.152456"},{"key":"2022061622264972600_B2","doi-asserted-by":"crossref","unstructured":"Barrett AJ, Horowitz MM, Pollock BH, et al. Bone Marrow transplant from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med\u20081994; 331: 1253\u20139.","DOI":"10.1056\/NEJM199411103311902"},{"key":"2022061622264972600_B3","unstructured":"Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reaction after bone marrow transplantation. Blood\u20081990; 78: 2120\u201330."},{"key":"2022061622264972600_B4","doi-asserted-by":"crossref","unstructured":"Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukaemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med\u20081998; 17: 1186\u201393.","DOI":"10.1056\/NEJM199810223391702"},{"key":"2022061622264972600_B5","doi-asserted-by":"crossref","unstructured":"Parkman R, Weinberg KI. Immunological reconstitution following bone marrow transplantation. Immunol Rev\u20081997; 157: 73\u20138.","DOI":"10.1111\/j.1600-065X.1997.tb00975.x"},{"key":"2022061622264972600_B6","doi-asserted-by":"crossref","unstructured":"Marmont AM, Horowitz MM, Gale RP, et al. T-cell depletion of HLA-identical transplants in leukemia. Blood\u20081991; 78: 2120\u201330.","DOI":"10.1182\/blood.V78.8.2120.bloodjournal7882120"},{"key":"2022061622264972600_B7","doi-asserted-by":"crossref","unstructured":"Kolb HJ, Schmid C, Barrett AJ, Schendel DJ. Graft-versus-leukemia reactions in allogeneic chimeras. Blood\u20082004; 103: 767\u201376.","DOI":"10.1182\/blood-2003-02-0342"},{"key":"2022061622264972600_B8","doi-asserted-by":"crossref","unstructured":"Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor Natural Killer cell alloreactivity in mismatched haematopoietic transplants. Science\u20082002; 295: 2097\u2013100.","DOI":"10.1126\/science.1068440"},{"key":"2022061622264972600_B9","doi-asserted-by":"crossref","unstructured":"Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood\u20082002; 100: 1935\u201347.","DOI":"10.1182\/blood-2002-02-0350"},{"key":"2022061622264972600_B10","doi-asserted-by":"crossref","unstructured":"Kolb HJ, Schattenberg A, Goldman JM, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood\u20081995; 86: 2041\u201350.","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041"},{"key":"2022061622264972600_B11","doi-asserted-by":"crossref","unstructured":"Collins RHJ, Shpilberg O, Drobyski WR, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol\u20081997; 15: 433\u201344.","DOI":"10.1200\/JCO.1997.15.2.433"},{"key":"2022061622264972600_B12","doi-asserted-by":"crossref","unstructured":"Montagna D, Maccario R, Locatelli F, et al. Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy. Blood\u20082001; 98: 3359\u201366.","DOI":"10.1182\/blood.V98.12.3359"},{"key":"2022061622264972600_B13","doi-asserted-by":"crossref","unstructured":"Montagna D, Maccario R, Montini E, et al. Generation and ex vivo expansion of cytotoxic T lymphocytes directed toward different types of leukaemia or myelodisplastic cells using both HLA-matched and partially matched donors. Exp Hematol\u20082003; 31: 1031\u20138.","DOI":"10.1016\/S0301-472X(03)00230-3"},{"key":"2022061622264972600_B14","doi-asserted-by":"crossref","unstructured":"Montagna D, Locatelli F, Calcaterra V, et al. Does the emergence and persistence of donor-derived leukaemia-reactive T lymphocytes protect patients given an allogeneic BMT from recurrence? Results of a preliminary study. Bone Marrow Transplant\u20081998; 22: 743\u201350.","DOI":"10.1038\/sj.bmt.1701419"},{"key":"2022061622264972600_B15","unstructured":"Montagna D, Arico\u0300 M, Montini E, De Benedetti F, Maccario R. Identification of HLA-unrestricted CD8+\/CD28\u2212 cytotoxic T cell clones specific for leukemic blasts in children with acute leucemia. Cancer Res\u20081995; 55: 3935\u20139."},{"key":"2022061622264972600_B16","doi-asserted-by":"crossref","unstructured":"Montagna D, Schiavo R, Gibelli N, et al. Ex vivo generation and expansion of anti-tumor cytotoxic T-cell lines derived from patients or their HLA-identical sibling. Int J Cancer\u20082004; 110: 76\u201386.","DOI":"10.1002\/ijc.20081"},{"key":"2022061622264972600_B17","doi-asserted-by":"crossref","unstructured":"Rukavina D, Balen-Marunic S, Rubesa G, Orlic P, Vuajaklija K, Podack ER. Perforin expression in peripheral blood lymphocytes in rejecting and tolerant kidney transplant recipients. Transplantation\u20081996; 61: 285\u201391.","DOI":"10.1097\/00007890-199601270-00021"},{"key":"2022061622264972600_B18","doi-asserted-by":"crossref","unstructured":"Avanzini MA, Belloni C, De Silvestri A, et al. Antigen-specific T cell response in infants after recombinant hepatitis B virus vaccination at birth: evaluation of T helper lymphocyte diversity. Clin Immunol\u20082003; 107: 122\u20138.","DOI":"10.1016\/S1521-6616(03)00047-0"},{"key":"2022061622264972600_B19","doi-asserted-by":"crossref","unstructured":"Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subset: function, generation and maintenance. Annu Rev Immunol\u20082004; 22: 745\u201363.","DOI":"10.1146\/annurev.immunol.22.012703.104702"},{"key":"2022061622264972600_B20","doi-asserted-by":"crossref","unstructured":"Marijt WAE, Heemskerk MHM, Kloosterboer FM, et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remission of relapsed leukaemia. Proc Natl Acad Sci U S A\u20082003; 100: 2742\u20137.","DOI":"10.1073\/pnas.0530192100"},{"key":"2022061622264972600_B21","doi-asserted-by":"crossref","unstructured":"Falkenburg JHF, Smit WM, Willemze R. Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukaemia. Immunol Rev\u20081997; 157: 223\u201330.","DOI":"10.1111\/j.1600-065X.1997.tb00985.x"},{"key":"2022061622264972600_B22","doi-asserted-by":"crossref","unstructured":"Pardoll DM, Topalian SL. The role of CD4+ cell responses on antitumor immunity. Curr Opin Immunol\u20081998; 10: 588\u201394.","DOI":"10.1016\/S0952-7915(98)80228-8"},{"key":"2022061622264972600_B23","doi-asserted-by":"crossref","unstructured":"Wang HI, Fu T, Wang G, et al. Induction of CD4+ T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells. J Clin Invest\u20082002; 109: 1463\u201370.","DOI":"10.1172\/JCI200215399"},{"key":"2022061622264972600_B24","doi-asserted-by":"crossref","unstructured":"Baxevanis C, Voutas IF, Tsitsolonis OE, Gritzapis AD, Sotiriadou R, Papamichail M. Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against tumor. J Immunol\u20082000; 164: 3902\u201312.","DOI":"10.4049\/jimmunol.164.7.3902"},{"key":"2022061622264972600_B25","doi-asserted-by":"crossref","unstructured":"Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte response: intermediates, effector and memory cells. Science\u20082000; 290: 92\u20137.","DOI":"10.1126\/science.290.5489.92"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/14\/7310\/2551118\/7310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/14\/7310\/2551118\/7310.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T01:25:23Z","timestamp":1655429123000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/14\/7310\/525886\/Single-Cell-Cloning-of-Human-Donor-Derived"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,15]]},"references-count":25,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2006,7,18]]},"published-print":{"date-parts":[[2006,7,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-0591","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,15]]}}}